Check this out this excerpt from a Web MD article last week:
I was recently asked to contribute copy for the 2014 Cure Magazine 8th Annual Cancer Guide. To aid my task, one of the editors passed along a link to last year’s guide for newly diagnosed patients. Outstanding! And certainly not out of date; most of the material isn’t time sensitive.
Immunotherapies have been hot topics at the last two ASH and ASCO conferences. That trend didn’t let up at this year’s American Society of Hematology annual meeting in New Orleans.
So much cancer related news I don’t know where to start. ASH started on Friday and continues this week. ASH stands for “American Society of Hematology,” and the annual meeting rotates among a half dozen southern convention venues large enough close to 30,000 researchers, nurses, doctors and drug company staffers. This makes ASH the largest gathering of hematologists in the world.
Breast cancer is always in the news. Here’s a pair of links from a website called FoodConsumer.org, touting supplements as a way to prevent it. See what you think:
I wanted to pass along news about an exciting new website, Kairoslife.com. My contact there, Mark, emailed me to explain how it works:
I haven’t read Jane Schwartzberg’s new book. But I’m looking forward to it. Like Jane, my bone marrow cancer is incurable. I’ve lived six years and hope to live six more. But the odds say I won’t make it past ten.
Immunotherapy is the hot topic in oncology these days. Anyone reading HWC regularly knows that! Here’s a lengthy excerpt from an even longer, more comprehensive article my good friend and lifestyle columnist for our daily MultipleMyelomaBlog.com (MMB), Danny Parker, passed-along last week:
My good friend, Purdue University researcher, Gary Blau, alerted me to this amazing NBC News Rock Center report about how smart phones are already changing the way some doctors treat patients:
Anna Edney’s Washington Post article about the high cost of cancer drugs doesn’t have anything to do with the sequester. This is an ongoing challenge for many of us:
I rarely post celebrity cancer news here. But the angle of ABC’s coverage intrigued me; the fact that Roger Ebert was such a good patient. He stayed positive and active way longer than most of us would have the courage to do.
I understand we have quite a few Canadian readers, both here and on my daily MMB. Thought this might be of interest, especially since Cytoxan–a drug sometimes used in a wide variety of patients including multiple myeloma, ovarian and breast cancers–was one of the under-dosed agents:
Before we move forward on this one, I would like to vent a bit. Curing cancer? What a radical idea! Working in teams? Mmm, let’s see. Oh yes, I had my middle school students practicing that almost 30 years ago.
I know, I know. It’s easy to become numb to the endless new cancer therapy developments that never seem to pan-out. Well, I believe this one is different. This is the real deal:
This is an alarming report! Here are two takes on things, beginning with the first part of an editorial from the New York Times, followed by another article about the report by the Boston Globe:
I usually post celebrity cancer news on CancerNews.US. But I felt making an exception this time would be OK. Steve Garvey a big name with what seems to be a big heart, too…
I admit it. I don’t own a smart phone. It is difficult for me to text due to my chemotherapy-induced peripheral neuropathy. So I found a phone with unusually big, real keys.
Interested in a quick and fascinating read? Check-out the first few paragraphs of this Saturday Evening Post article I read last week:
Who names these bills? Recalcitrant Cancer Research Act passed Friday. Here is the accompanying press release:
We understand that we haven’t been sharing as much nutritional and lifestyle information here as we usually do. There has just been a lot of interesting and important cancer related new lately.